Skip to content
‹ Back to IndustriesHealthcare

How Risk Screening Ultimately Reduces Overall Healthcare Costs & Improves Results

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for the early diagnosis of disease is risk screening. So if risk screenings are so valuable, why don’t patients take advantage of these preventative services more often? Let’s take a look.

The High Cost of Waiting

Studies have shown that early detection of certain cancers and other chronic diseases through screening can reduce mortality by 15 to 20 percent. Not only does risk screening prevent complications by diagnosing health conditions early, it can actually help patients—and the healthcare system as a whole—save money. For example, in 2012 Alan Katz, Executive Vice President of SeeChange Health, testified that the average annual cost of early-stage treatment of breast cancer for a single patient is about $14,000 per year compared with $61,000 for late-stage treatment. Other examples of risk screening procedures that help drive down healthcare costs include colonoscopies, pulmonary embolism risk assessment, and screenings for obesity, and tobacco and alcohol use.

So Why Isn’t Risk Screening Used More Often?

Out of pocket insurance costs are a top reason more people don’t schedule risk screenings. According to Thompson Reuters, the costs of mammograms, colonoscopies, and MRIs for Americans with employer-sponsored insurance can be two to three times higher than the median price in the same market. In addition, patients may simply be unaware of the specific risk screenings that are available to them because they do not regularly communicate with a primary care physician. Finally, when a patient does decide to get a screening, they may find the process for scheduling an appointment cumbersome and time-consuming.

ChartLogic Has the Tools to Make Scheduling Risk Screenings Easier

ChartLogic’s Connect Patient is a multifunction patient portal and communications platform that works with any device or browser. Physicians and patients can use this powerful technology tool to quickly and easily engage, enhancing the overall patient experience and improving quality by allowing patients to be more active participants in their own care. Patients can easily schedule appointments, send and receive messages from their doctor, view lab results, request prescription refills, and make payments. Best of all, Connect Patient integrates with ChartLogic’s comprehensive ambulatory EHR suite that includes Electronic Medical Records, Practice Management, and Billing Services.

Read more at chartlogic.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Luminopia's CEO says payer churn slows coverage and can require patching first

Luminopia's CEO says payer churn slows coverage and can require patching first

Luminopia co-founder and CEO Scott Xiao told HLTH's Partner Highlight series that short payer member tenure and a fragmented Medicaid leave pediatric amblyopia neglected. A 2025 JMCP payer roundtable recommended covering the FDA-authorized therapy but allowed step-edits, while PEDIG data show two-hour patching adds about 1.1 lines of acuity. Cleveland Clinic registry data report 1.8 lines of gain in severe cases.

  • 01A 2025 payer roundtable in the Journal of Managed Care & Specialty Pharmacy recommended plans cover Luminopia, yet said step-edits and letters of exception may still be required, with more than 9,000 prescriptions written since November 2022.
  • 02PEDIG's ATS05 trial put two hours of daily patching at 1.1 lines of gain over five weeks versus 0.5 lines for glasses alone, while a 2015 AAO review tied patching's poor compliance to social stigma.
  • 03S.1702, the Access to Prescription Digital Therapeutics Act of 2025, has sat in the Senate Finance Committee since May 8, 2025, leaving coverage negotiated plan by plan.

Nov 19, 2026

AHA and BD's 10-hospital pilot tests who acts on surgical blood pressure readings

AHA and BD's 10-hospital pilot tests who acts on surgical blood pressure readings

The American Hospital Association, West Health and BD will add continuous blood pressure monitoring to surgical care at 10 hospitals, with Vizient measuring results. The pilot tests the workflow around the device: who notices a change, who acts and who hands it off. Whether it spreads depends on cost after startup funding ends.

  • 01A monitor running in two operating rooms can support two different decisions, so device usage counts can say little about whether continuous blood pressure monitoring actually changed surgical care.
  • 02Hospitals evaluating continuous monitoring may already own idle devices; learning why they sit unused, whether training time or an awkward spot in the workflow, points to a different fix than a new purchase order.
  • 03A playbook is expected in roughly a year, aiming to define essential steps while leaving room for smaller or resource-limited hospitals—such as those without 24/7 pharmacy coverage—to adapt workflows locally.

Nov 19, 2026

Four renewal questions that can bring HbA1c closer to the dental chair

Four renewal questions that can bring HbA1c closer to the dental chair

Dr. Deepashree Rajendraprasad, a dentist turned hospital business intelligence developer, gives dental practices four questions for software vendors at contract renewal. They cover HL7 FHIR APIs, health information exchange access, SNODENT terminology and electronic referrals. The standards already exist. The payoff shows up chairside in anticoagulant screening, diabetes-guided periodontal care and bisphosphonate surgical planning.

  • 01Rajendraprasad argues that HbA1c is often already structured in medical systems; getting it to the dental chair starts with what a practice asks its software vendor.
  • 02Two of the five FHIR resources most relevant to dentistry, Patient and Observation, belong to the normative core of FHIR Release 4, where future changes are meant to stay backward compatible.
  • 03At renewal, ask vendors specifics: which FHIR resources they expose, whether they can query the regional HIE, whether they code in SNODENT, and whether they support structured referrals.

Nov 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512